# Endofotonics Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/endofotonics-pte

- Industry: Medical Devices & Equipment
- Headquarters: Singapore, Singapore
- Website: www.endofotonics.com
- Total disclosed funding: $9.3M
- Latest round: Series B (Oct 31, 2022)
- Investors on record: 3

## About

Endofotonics Pte. Ltd. specializes in advanced imaging solutions for real-time diagnostics in medical settings, improving accuracy in oncology and other fields through innovative technology.Founded in 2013, Endofotonics Pte. Ltd. is headquartered in Singapore and focuses on developing imaging technologies for medical diagnostics. The company has completed three deals, with the latest funding round being a Series B in October 2022, which raised USD 7.93 mn from investors including Harleys Investments Pte. Ltd., SEEDS Capital, and ZIG Ventures. The total amount raised by the company is USD 7.93 mn, valuing it at USD 11.576 mn. Lawrence Ho is the founder, and Peter Kum serves as the CEO.Endofotonics specializes in advanced imaging solutions designed for real-time diagnostics in medical applications. The company’s flagship product utilizes advanced technology to provide precise visualizations of cellular and tissue structures, enabling healthcare professionals to make informed decisions during procedures. Targeting critical use cases in oncology and other medical fields, these products enhance the accuracy of diagnostics and improve patient outcomes. Endofotonics primarily serves hospitals and diagnostic laboratories, catering to a global market that includes North America, Europe, and select regions in Asia.Endofotonics generates revenue through direct sales of its proprietary imaging systems to healthcare institutions and diagnostic centers, emphasizing a business-to-business (B2B) model. Transactions typically involve one-time purchases of equipment, accompanied by ongoing support and maintenance services to ensure operational efficiency. The company may also offer subscription-based access to software updates or cloud-based data management services. Pricing structures for these offerings are aligned with industry standards, reflecting the advanced technology and specialized applications of the products. In 2021, the company reported an EBITDA of USD -1,288,349.50.Endofotonics plans to leverage its recent Series B funding, raised on October 31, 2022, totaling USD 7.93 mn, to drive product development and market expansion. The funding will support the launch of new imaging products aimed at enhancing diagnostic capabilities, with specific details on release dates to be determined. Additionally, the company intends to expand its reach into new markets, particularly in Europe and Asia, by the end of 2023. This strategic growth will enhance the company’s positioning in the healthcare technology sector.

## Funding rounds

- Series B, Oct 31, 2022, $7.9M — SEEDS Capital, ZIG Ventures, Harleys Investments Pte. Ltd.
- Series A, Nov 30, 2016, $1.4M — SEEDS Capital, ZIG Ventures

## Investors

- SEEDS Capital (https://capitalatlas.ai/funds/seeds-capital) — Series A, Series B
- ZIG Ventures (https://capitalatlas.ai/funds/zig-ventures) — Series A, Series B
- Harleys Investments Pte. Ltd. — Series B